Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model
/in Colorectal Cancer, Dendritic Cells, International PublicationsMulticenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaIFN{gamma} markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models
/in Dendritic Cells, International PublicationsDendritic cell vaccination of patients with metastatic colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International PublicationsHarnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer
/in Dendritic Cells, International Publications, Prostate CancerImmunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma
/in Dendritic Cells, Endometrial Cancer, International PublicationsDendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients
/in Dendritic Cells, International Publications, Malignant MelanomaDendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer]
/in Dendritic Cells, International Publications, Prostate Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer